DK0928201T3 - Nye Glycolipidkomplekser og deres anvendelse - Google Patents

Nye Glycolipidkomplekser og deres anvendelse

Info

Publication number
DK0928201T3
DK0928201T3 DK97923373T DK97923373T DK0928201T3 DK 0928201 T3 DK0928201 T3 DK 0928201T3 DK 97923373 T DK97923373 T DK 97923373T DK 97923373 T DK97923373 T DK 97923373T DK 0928201 T3 DK0928201 T3 DK 0928201T3
Authority
DK
Denmark
Prior art keywords
glycolipid
complex
diagnostic methods
glycolipid complexes
new glycolipid
Prior art date
Application number
DK97923373T
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Jan-Eric Mansson
Original Assignee
A & Science Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Ab filed Critical A & Science Ab
Application granted granted Critical
Publication of DK0928201T3 publication Critical patent/DK0928201T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97923373T 1996-05-13 1997-05-10 Nye Glycolipidkomplekser og deres anvendelse DK0928201T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses
PCT/SE1997/000769 WO1997042974A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses

Publications (1)

Publication Number Publication Date
DK0928201T3 true DK0928201T3 (da) 2002-12-23

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97923373T DK0928201T3 (da) 1996-05-13 1997-05-10 Nye Glycolipidkomplekser og deres anvendelse

Country Status (12)

Country Link
US (2) US6352831B1 (da)
EP (1) EP0928201B1 (da)
JP (1) JP2000513332A (da)
AT (1) ATE222775T1 (da)
AU (1) AU728141B2 (da)
CA (1) CA2253883A1 (da)
DE (1) DE69715014T2 (da)
DK (1) DK0928201T3 (da)
ES (1) ES2183177T3 (da)
PT (1) PT928201E (da)
SE (1) SE9601817D0 (da)
WO (1) WO1997042974A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492337B1 (en) 1997-12-30 2002-12-10 A+ Science Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complication
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
DE602006019759D1 (de) * 2005-09-29 2011-03-03 Torrey Pines Inst Sulfatide zur behandlung von autoimmunkrankheiten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
DK0675727T3 (da) 1992-12-10 2002-08-05 Enzon Inc Glycolipidenzympolymerkonjugater

Also Published As

Publication number Publication date
EP0928201A1 (en) 1999-07-14
SE9601817D0 (sv) 1996-05-13
HK1021321A1 (en) 2000-06-09
JP2000513332A (ja) 2000-10-10
US6352831B1 (en) 2002-03-05
US20020034769A1 (en) 2002-03-21
DE69715014T2 (de) 2004-02-26
DE69715014D1 (de) 2002-10-02
AU2918897A (en) 1997-12-05
AU728141B2 (en) 2001-01-04
WO1997042974A1 (en) 1997-11-20
ATE222775T1 (de) 2002-09-15
ES2183177T3 (es) 2003-03-16
EP0928201B1 (en) 2002-08-28
CA2253883A1 (en) 1997-11-20
PT928201E (pt) 2003-01-31

Similar Documents

Publication Publication Date Title
SE7510807L (sv) Till plastmaterial konvalent bundna biologiska substanser och deras anvendning i radioanalys
YU47648B (sh) Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena
ES2038109T1 (es) Un proceso para la produccion de un compuesto alqueno.
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
SE9301270D0 (sv) Biosensor
KR830010384A (ko) 항원 항체 반응의 측정 방법 및 그 시약
DK0564494T3 (da) Testmetode og reagenssæt dertil
ES8507692A1 (es) Un procedimiento para preparar un trazador para uso en ensayo no isotopico
DK0928201T3 (da) Nye Glycolipidkomplekser og deres anvendelse
SE8300320D0 (sv) Monoclonal antibody formulation for diagnostic use
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
ES456913A1 (es) Un metodo para la preparacion de eritrocitos estabilizados.
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
ATE90790T1 (de) Verfahren zur herstellung einer festphasenmatrix.
DK152506C (da) Geldannende polysakkarid, fremgangsmaade til dets fremstilling og anvendelse af det
FR2397449A1 (fr) Produits conjugues chimioluminescents biologiquement actifs et leur utilisation
IT8024762A0 (it) Procedimento per spostare un sistema mobile rispetto ad un supporto d'informazioni e dispositivo per la sua messa in opera.
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DK398086D0 (da) Fremgangsmaade til foroegelse af oploeseligheden af immunokonjugatpraeparationer eller ukonjugeret immunoglobulin samt fremgangsmaade til nedsaettelse af intakte toksinkonjugaters toksicitet
SU1304398A1 (ru) Штамм VIвRIо NaG 62 серовара,используемый дл приготовлени диагностической сыворотки против вибрионов 62 серовара
KR860008779A (ko) 항체 형성 화합물의 제조방법
SU694157A1 (ru) Лабораторный инкубатор
ZA98587B (en) A novel antigen from P. aeruginosa, and its use in medicine.
Kagan et al. Some antigenic features of group B streptococcal L-forms.